← FDA Warning Letters

Ozempen.com

FDA Warning Letter · 2024-07-02 · Center for Drug Evaluation and Research | CDER

Letter

Company
Ozempen.com
Posted Date
2024-07-02
Letter Issue Date
2024-06-24
Issuing Office
Center for Drug Evaluation and Research | CDER

Subject

Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet

Source

Authoritative
FDA Warning Letters
Machine
JSON-LD · Markdown